A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy

Shiyong Li, Rima J. Couzi, George H. Thomas, Alan D. Friedman, Michael J. Borowitz

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

We report a case of acute myelomonocytic leukemia with eosinophilia (AML-M4eo) in a 65-year-old man following low dose methotrexate treatment for pemphigus vulgaris. Cytogenetic studies at diagnosis revealed a complex karyotype including a reciprocal translocation between 11q14.2 and 16q22, an inversion of chromosome 16(p13.1q22), and an apparently terminal deletion of 7q31. The presence of inv(16) was confirmed by reverse transcription-polymerase chain reaction which demonstrated a Type A fusion transcript derived from the core binding factor (CBF) β and the smooth muscle myosin heavy chain (MYH11) genes. The patient was in complete hematologic and cytogenetic remission 6 months following intensive chemotherapy. Because AML-M4eo with inv(16) has a favorable prognosis, molecular studies should be performed in case the identification of inv(16) by conventional cytogenetics is difficult due to a complex karyotype.

Original languageEnglish (US)
Pages (from-to)74-77
Number of pages4
JournalCancer Genetics and Cytogenetics
Volume125
Issue number1
DOIs
StatePublished - 2001

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint

Dive into the research topics of 'A novel variant three-way translocation of inversion 16 in a case of AML-M4eo following low dose methotrexate therapy'. Together they form a unique fingerprint.

Cite this